[FAQ9_code]

Explaining If Grant Funding Disqualifies a Company from R&D Tax Credits: Navigating the Funded Research Exclusion

I. Executive Summary: Grant Funding is Not a Disqualification

The Research and Development (R&D) Tax Credit, codified under Internal Revenue Code (IRC) Section 41, remains one of the most significant domestic tax incentives available to U.S. businesses. Designed to spur innovation and encourage investment in research activities, the credit was made permanent by the Protecting Americans from Tax Hikes Act of 2015 (PATH Act).1 The magnitude of this incentive is substantial; for example, in the 2014 tax year, corporations claimed over $12.5 billion in R&D credits across nearly 18,000 corporate returns, demonstrating its importance across various sectors, including manufacturing, information, and professional services.2

However, companies leveraging grants, especially those targeting government programs like the Small Business Innovation Research (SBIR) or Small Business Technology Transfer (STTR), frequently encounter a critical challenge: the Funded Research Exclusion.

The core of the issue lies in IRC Section 41, which explicitly states that research does not constitute qualified research to the extent it is funded by any grant, contract, or otherwise by another person or governmental entity.3 The intent of this exclusion is clear: to prevent taxpayers from utilizing government funding to conduct research and then simultaneously claiming a tax incentive on those same expenditures, a concept often referred to as “double-dipping.”

The Nuanced Answer: Segregation is Key

The critical finding for innovative companies is that grant funding does not result in an automatic, wholesale disqualification of the R&D project. Instead, it triggers a stringent, mandatory requirement to legally and financially separate qualified, self-funded research expenses (QREs) from the externally funded portion.5 If a company can prove that certain costs were incurred at its own risk and paid for by the business, those specific costs may still qualify for the credit, even if the overall project received external funding.5

The Cost of Non-Compliance: Heightened Audit Risk

Failing to properly account for and segregate funding sources is a major compliance pitfall that frequently leads to overstated credits and exposure to potential penalties during an audit.5 In the current regulatory environment, the Internal Revenue Service (IRS) is undertaking more intense and detailed examinations of R&D tax credit claims.6

With the IRS relying more heavily on the information provided by taxpayers, incomplete, disorganized, or poorly substantiated claims related to the funded research exclusion are immediate red flags, likely triggering a protracted and rigorous examination.6 Therefore, the funded research exclusion must be treated not merely as a compliance checklist item, but as a critical component of proactive, audit-defensible tax strategy.

II. The Funded Research Exclusion: Legal Foundation and Statutory Tests

The process of determining whether research is funded hinges on a detailed analysis of the underlying legal agreements—not just formal research contracts, but all agreements entered into between the taxpayer performing the research and other persons.7 This analysis is defined by a mandatory, two-pronged legal test derived from Treasury Regulations and extensive judicial opinions, which assess who truly pays for and owns the results of the research.

Statutory Basis and Scope

The prohibition against claiming the R&D credit for funded research is rooted directly in IRC Section 41. The definition of “funded research” is expansive, encompassing funds provided by any grant, contract, or other mechanism by another person, including governmental entities.3

To satisfy the funded research exclusion and claim the expenses as “unfunded,” the taxpayer must overcome two non-negotiable hurdles related to the expense:

1. The Economic Risk Standard: Did the taxpayer bear the financial risk of failure?
2. The Substantial Rights Standard: Did the taxpayer retain ownership rights to the research results? 7

A. Test 1: The Economic Risk Standard

The economic risk standard requires the taxpayer claiming the credit to demonstrate that they are the party with “something to lose” if the research effort fails.7 The focus is on the contingency of payment.

Guaranteed Payment vs. Risk Absorption

Research is typically deemed funded if the performing company receives a guaranteed payment, regardless of whether the research yields successful results. This situation often arises in “cost-plus” contracts or government grants where payment is disbursed upfront or based on time and materials, not contingent upon achieving a specific scientific or technical success.5 In such cases, the entity providing the funding, not the taxpayer, bears the economic risk, disqualifying the expense.5

Conversely, expenses may qualify as unfunded if the performing company must absorb the costs associated with failed experiments or if payment from the funding entity is contingent on the achievement of successful milestones.5 By incurring the cost of failed research, the performing company demonstrates that it bears the requisite economic risk, allowing those specific, un-reimbursed costs to be potentially included as QREs.

B. Test 2: The Substantial Rights Standard

The second test focuses on the ownership and commercial utility of the research results, specifically the Intellectual Property (IP) developed during the project.

IP Ownership and Exploitation

For the research to be considered unfunded, the taxpayer must retain “substantial rights” to the research results, giving them the right to exploit, use, or commercialize the resulting technology.8 If the grant or contract language requires the exclusive transfer of all IP rights to the funding entity (such as a governmental body or a client), the research is deemed funded, regardless of which party initially bore the financial risk.8

The regulatory environment increasingly demands clarity on this point. Recent IRS guidance, while primarily addressing specified research and experimentation (SRE) expenditures under IRC Section 174, formally reinforces the need for taxpayers performing research under contract to retain the right to exploit the results.8 This regulatory alignment confirms that the retention of substantial rights remains a core, necessary element for justifying R&D-related tax benefits.

Contract Language is Tax Law

The statutory framework of the funded research exclusion deliberately pushes the interpretive burden onto the specifics of the contract or grant agreement.7 This means that seemingly minor phrases regarding payment structure, risk transfer, or IP retention—often buried in technical scopes of work—can determine the eligibility of millions of dollars in potential tax credits. Tax planning must therefore be integrated directly with contract negotiation and review, ensuring that agreements are structured to isolate and protect the taxpayer’s retained risk and IP rights.

III. Navigating Government Grants: SBIR/STTR and Separation Strategies

Government grants, particularly the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs, are crucial funding mechanisms for early-stage technology companies but present classic examples of funded research complexity.9 Successfully integrating these grants with R&D tax credits requires a nuanced understanding of their structure and a commitment to stringent financial separation.

A. Analyzing SBIR and STTR Grants

The SBIR/STTR programs employ a competitive, phased structure aimed at fostering innovation.10 Analyzing each phase is necessary for determining credit eligibility:

Phase I: Feasibility

Phase I involves soliciting proposals to conduct feasibility-related experimental or theoretical R&D.10 Given the relatively small, upfront investments and the focus on proving scientific or technical merit, Phase I funding often covers the entire scope of the initial feasibility work. Since the payment is typically guaranteed and the risk is low for the performer, expenses in this phase are frequently entirely excluded from the R&D credit.

Phase II: Research and Development

Phase II awards represent larger investments and focus on R&D necessary to move the project toward commercialization.10 This phase presents the greatest opportunity for partial claims. The R&D credit can often be claimed on the costs that exceed the grant funding, provided those cost overruns or incremental expenses were borne solely by the company to pursue a commercial objective independent of the government’s guaranteed deliverable.5

Phase III: Commercialization

Phase III involves activities focused on commercial application and production, typically without new SBIR/STTR funding.10 Research costs incurred after commercial production begins are generally excluded from the R&D credit, regardless of funding source, as they often fail the four-part test for qualified research.4

The Strategic Value of Cost Separation

The core strategy for maximizing R&D credit eligibility when grants are involved is the “white space” strategy: identifying and documenting research expenses that fall outside the defined, funded scope of the grant.5 This requires maintaining clear financial separation between self-funded and externally funded research.5

Government grants, especially STTR agreements, often mandate formal agreements detailing the split of IP rights and research effort—for instance, requiring the small business partner to conduct at least 40% of the research.9 These bureaucratic requirements, while challenging, provide a crucial opportunity for tax defense. The resulting detailed reports, IP agreements, and financial documentation can be directly cross-referenced to prove the self-funded, retained-rights portion of the work, thereby transforming a potential audit risk into a substantiated claim.

Documentation Mandate

To substantiate claims involving grants, companies must establish robust systems for tracking costs:

• Time Tracking: Employee wages, which typically account for the largest QRE category, must be allocated accurately. Rigorous, contemporaneous time-tracking systems and project codes are essential for differentiating between labor hours spent on funded activities and those spent on self-funded, incremental R&D.11
• Invoicing and Materials: Companies must retain detailed supply invoices and records of contractor costs that explicitly document the connection between the expense and the qualified research activity, demonstrating whether the expense was paid by the company or reimbursed by the grant.12

Without meticulous, project-level cost segregation, the ability to substantiate a claim for the self-funded portion is lost, and the IRS will default to highly restrictive allocation rules.

IV. Compliance Mechanics: Allocation and the Critical 65% Rule

When research activities are only partially funded, the method used to allocate the expenses between the qualified (unfunded) and non-qualified (funded) portions is technically complex and highly scrutinized by the IRS. The chosen allocation method often determines the final available credit amount.

A. The General Rule: Punitive 100% Allocation

Treasury Regulation section 1.41-4A(d)(3)(i) establishes a punitive default position: if a taxpayer cannot definitively substantiate the exact allocation of the funding across different research activities, the funding is allocated 100 percent against the otherwise qualified research expenses (QREs).13 This rule operates on the presumption that the funding source paid for the most valuable, credit-eligible portion of the research first, which often eliminates the potential tax credit entirely.

B. The Pro Rata Allocation Exception (The 65% Rule)

To avoid the punitive 100% allocation, a taxpayer must meet the specific requirements of Treasury Regulation section 1.41-4A(d)(3)(ii) to utilize the favorable pro rata allocation methodology. This allows the funding to be spread across both non-qualified and otherwise qualified research expenses, thus preserving a portion of the QREs for the credit calculation.13

The taxpayer may use the pro rata allocation only if they can establish, to the satisfaction of the Service, the following three prerequisites 13:

1. Total Research Expenses: The taxpayer must accurately establish the total amount of research expenses for the entire project.
2. Excess of Expenses: The total research expenses must exceed the amount of funding received.
3. The 65% Threshold: The otherwise qualified research expenses (QREs) must exceed 65 percent of the funding received.

Strategic Interpretation of the 65% Rule

The requirement that QREs exceed 65 percent of the funding is a critical threshold that governs eligibility for the pro rata exception.13 It is important to note that this is not a credit floor. In no event shall less than 65 percent of the funding be applied against the otherwise qualified research expenses.13 This rule primarily benefits taxpayers in cost-overrun or cost-share arrangements where the taxpayer demonstrably covers substantial incremental costs beyond the funding amount.

If the specific documentation requirements related to total expenses and the 65% ratio are not met, the IRS is warranted in making material adjustments by reverting to the 100% allocation rule.13 This high-level requirement serves as an audit filter; only companies with exceptionally robust, granular internal accounting systems can safely qualify for and utilize the pro rata exception.

Undetermined Funding

A specific complication arises when the final amount of funding is impossible to determine at the time the tax return is filed (common with complex multi-year grants or contracts). In this scenario, the taxpayer is required by regulation to treat the research as completely funded when filing the initial return. Once the final funding amount is determined, the taxpayer must amend the return and any interim returns to reflect the proper, calculated amount of funding.13

The following table summarizes the strategic implications of contract structure on R&D credit eligibility:

Funded Research Allocation Scenarios

V. Mitigating Audit Risk: The Documentation Imperative in a New Era

The landscape for R&D tax credit claims has shifted dramatically toward stricter documentation and upfront substantiation.11 For companies managing grant funding exclusions, documentation is the single most critical factor in achieving defensibility.

A. The Evolving IRS Compliance Landscape

The IRS’s commitment to increased compliance requirements is evident in recent guidance and court decisions. While overall audit rates may have dropped, the intensity and detail of R&D audits have increased.6 This necessitates a move toward filing audit-ready claims.

Procedural Risk and the Harper Decision

Recent case law, such as the Harper decision 11, underscores the significant procedural risks associated with inadequate documentation. The case demonstrated that even voluminous documentation may be insufficient if the original filing—Form 6765, Credit for Increasing Research Activities—lacks the required specificity to inform the Commissioner of the exact basis for the claim.11 The risk of procedural objection by the IRS, even years into an audit, mandates that claims must be highly specific, identifying applicable business components and costs upfront.11

B. Best Practices for Segregating QREs

Maximizing the R&D credit demands rigorous cost tracking, requiring collaboration among finance, engineering, and operations departments.11 Companies must establish systems for tracking costs on a per-project basis, particularly for distinguishing funded from self-funded activities.

Contemporaneous and Specific Records

To be prudent, documentation must be created contemporaneously with the research activities.12 The documentation must go beyond generic reports and include evidence that directly links costs to the four-part test and to the portion of the project that was not reimbursed by the grant:

• Evidence of Experimentation: Records should include iterations of design specifications, engineering drawings, internal presentations, meeting notes, and documentation of test outcomes, including failures.12
• Financial Traceability: Time-tracking systems and supply invoices must provide explicit detail connecting the cost to the activity and demonstrating whether it was a self-funded QRE.12
• Segregation Mandate: Clear accounting records that isolate reimbursed expenses from self-funded QREs are a foundational requirement for satisfying the three-part test necessary for the pro rata allocation exception.5

Disorganized or generic claims are immediate liabilities.12 The primary tax strategy must be to file an accurate, audit-ready claim, ensuring that the documentation package can preemptively address the two-pronged funded research test (Risk and Rights) and the complex allocation requirements (the 65% rule).13

VI. Swanson Reed: The Authority on Navigating Exclusion Complexity

Swanson Reed specializes in managing all facets of the R&D tax credit claim process, including providing audit advisory services before the IRS and state authorities.4 The firm’s methodology is anchored in a conservative, audit-defensible approach, which has become an industry standard.14 This specialization is vital when navigating the funded research exclusion, which represents one of the most technical and high-risk aspects of the credit.

A. Leveraging Proprietary AI for Compliance and Preparation

The necessary rigor required to satisfy the funded research exclusion—specifically, the data aggregation for the two-pronged test and the cost modeling for the 65% allocation rule—is efficiently managed through Swanson Reed’s proprietary technology tools.

TaxTrex: Precision in Claim Preparation

TaxTrex, a leading AI language model, is utilized for the rapid and accurate preparation of R&D tax credit claims.14 This technological advantage allows for exceptional speed and precision in claim calculation. For companies dealing with grants, this means the platform can quickly model complex cost segregation scenarios, assess the financial data against the three requirements of the 65% rule, and ensure that QRE calculations accurately reflect the retained IP and risk profile of the self-funded work.

creditARMOR: Preemptive Audit Defense

A crucial solution for mitigating the risks inherent in funded research claims is creditARMOR, an AI R&D Tax Audit management product.14 creditARMOR is specifically designed to address the current era of detailed IRS scrutiny, which penalizes claims lacking specificity and organization.6

creditARMOR delivers an audit assurance report that reviews the costing documentation and credit calculations in a manner identical to how an IRS examiner would conduct an audit.14 This preemptive validation is essential for funded research claims because it:

1. Identifies Risk Issues: It stress-tests compliance with the Economic Risk and Substantial Rights standards by reviewing contractual language and IP clauses.
2. Validates Allocation: It verifies that the underlying documentation supports the total research expense and the QRE ratio required to utilize the pro rata allocation exception (the 65% rule).13
3. Facilitates Defense: Should an audit occur, creditARMOR assists in preparing detailed, technically sufficient Information Documentation Responses to IRS questionnaires, ensuring the client has a defensible claim backed by a low-risk, long-term tax planning strategy.14

The ability of specialized AI tools like creditARMOR to proactively validate documentation against IRS audit standards provides a critical advantage, moving the client from a reactive defense position to a proactive, defensible position, particularly regarding the highly technical funded research exclusion.

VII. Conclusion: Compliance as a Strategic Advantage

The fundamental answer to whether grant funding disqualifies a company from R&D tax credits is that it does not, provided the company exercises stringent compliance diligence. The exclusion only applies to the extent that the research fails the statutory two-pronged test—where the company bears neither the Economic Risk nor retains Substantial Rights to the research results—or where the company fails to properly segregate and allocate costs.

For high-growth companies utilizing government grants (such as SBIR/STTR), the integration of grants and R&D credits requires moving beyond routine accounting practices to employ specialized tax expertise. Maximizing the R&D credit depends entirely on proving the self-funded, incremental portion of the research and surviving IRS procedural scrutiny.

Navigating the complexities of contract analysis and financial allocation, particularly the demanding requirements of the 65% pro rata rule, necessitates systems that can handle large volumes of technical and financial data with precision. By leveraging specialized AI tools, such as TaxTrex for preparation accuracy and creditARMOR for preemptive audit assurance, companies can transform the compliance burden of the funded research exclusion into a strategic advantage, maximizing the tax benefit while securing defensibility in the evolving era of IRS scrutiny.

R&D Tax Credit Preparation Services

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.

If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.

R&D Tax Credit Audit Advisory Services

creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.

Our Fees

Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/